Skip to main content

Medicine shortages Saarland update: In Saarland as in other parts of Germany, the pharmacists and doctors continue to have issues with supplying life-saving medicines to their patients. The main reason according to the local health care specialists is that their manufacturing is mainly in non-European countries. Hundreds of medicines are difficult or impossible to provide, including antibiotics, cardiovascular and diabetes drugs, and severe painkillers such as morphine, according to the chairwoman of the board of the Pharmacists’ Association, Susanne Koch, the SR.

Michael Kulas of the Saarland General Practitioners’ Association also continues to take a critical view of the situation. It is not as dramatic as last year when there was a lack of medicines for children in particular. But as long as production is almost exclusively abroad, the supply situation is unstable.

Benedikt Brixius of the Professional Association of Pediatricians and Adolescents in Saarland also supports his colleagues in their worries about the missing medicines. A solution to stimulate more companies to start manufacturing in Germany again might be different long-term financial incentives the government offers. Although it’s been an EU official strategy since 2020, mainly the costs of the new plants delay its fulfillment, respectively in the medicine supply many fluctuations occur.

Source of this news article update on Medicine shortages Saarland: SR.de: Again numerous medicines are missing in Saarland

Disclaimer:

As a service to our readers, MVS Pharma GmbH publishing provides access to our library of archived content — in our blogPlease note the date of the last review or update on all articles. No content on this site should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

MVS Pharma GmbH will soon be launching an omega-3 dietary supplement onto the European market that has been developed for the highest quality standards in terms of oxidation avoidance and therefore, the greatest bioavailability. In addition, in vitro studies are currently underway at the University of Ulm, in which Professor Dr. Rüdiger Groß tested a patented mouth and nose spray (Virudol) that can eliminate various flu viruses based on natural substances. In addition, MVS has a wholesale license and has specialized in sourcing much-needed medicines such as Amoxicillin, Salbutamol, etc. from India through its local branch with a focus on local quality and safety testing, compliance with international GMP regulations and the highest quality level of user security (examples of local language brochures, identical units of measurement, batch control and full tracking, etc.).

Managing Director of MVS Pharma Bulgaria Ltd Miglena Racheva

Miglena is the Managing Director of MVS Pharma Bulgaria Ltd. She is in charge of our Administration Company in Bulgaria – MVS Pharma Bulgaria Ltd. She makes sure that all the documentation complies with EU’s regulations, executes deep dive researches on various projects and topics, and oversees every plan and action of the company.